Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics, Inc. Message Board

  • okurrightimwrong okurrightimwrong Feb 14, 2013 5:58 PM Flag

    Compugen/SGEN research collaboration

    What happened to this collaboration?
    Compugen Licenses Novel Oncology Target to Seattle Genetics
    Agreement provides Seattle Genetics with research license and option for exclusive commercial license to monoclonal antibody-based therapeutics targeting Compugen-discovered target

 
SGEN
41.86+0.62(+1.50%)2:33 PMEDT